Home › FDA panel backs inhaler drug for lung disease
 

Keywords :   


FDA panel backs inhaler drug for lung disease

2013-04-18 01:27:50| Biotech - Topix.net

A panel of respiratory experts has voted in favor of approving an experimental inhaler drug from GlaxoSmithKline and Theravence for treating chronic lung disease.

Tags: panel drug disease lung

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
26.11PPG Completes Sale of Silicas Products Business to QEMETICA
26.11EPA releases draft farm emissions methodologies
26.11GibsonSG
26.11Dimarzio DP419 area67 2
26.11110
26.11
26.11tnqnp671
26.11SchucoClassic
More »